A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引:456
|
作者
PETRELLI, N
HERRERA, L
RUSTUM, Y
BURKE, P
CREAVEN, P
STULC, J
EMRICH, LJ
MITTELMAN, A
机构
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263
关键词
D O I
10.1200/JCO.1987.5.10.1559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1559 / 1565
页数:7
相关论文
共 50 条
  • [1] ADVANCED COLORECTAL-CARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL OF SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL, AND LEUCOVORIN VERSUS 5-FLUOROURACIL ALONE
    MACHIAVELLI, M
    LEONE, BA
    ROMERO, A
    RABINOVICH, MG
    VALLEJO, CT
    BIANCO, A
    PEREZ, JE
    RODRIGUEZ, R
    CUEVAS, MA
    ALVAREZ, LA
    CHACON, R
    HANNOIS, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (03): : 211 - 217
  • [3] MODIFICATION OF 5-FLUOROURACIL ACTIVITY BY HIGH-DOSE METHOTREXATE OR LEUCOVORIN IN ADVANCED COLORECTAL-CARCINOMA
    SINNIGE, HAM
    SLEIJFER, DT
    DEVRIES, EGE
    WILLEMSE, PHB
    MULDER, NH
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (05) : 625 - 628
  • [4] A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    Gennatas, C.
    Papaxoinis, G.
    Michalaki, V.
    Mouratidou, D.
    Andreadis, Ch.
    Tsavaris, N.
    Pafiti, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (05) : 538 - 544
  • [5] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL, AND CALCIUM LEUCOVORIN COLORECTAL-CARCINOMA
    HANSEN, RM
    RITCH, PS
    ANDERSON, T
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (04): : 352 - 354
  • [6] Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion
    H. T. Arkenau
    K. Rettig
    R. Porschen
    International Journal of Colorectal Disease, 2005, 20 : 258 - 261
  • [7] Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion
    Arkenau, HT
    Rettig, K
    Porschen, R
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2005, 20 (03) : 258 - 261
  • [8] Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin
    Pronzato, P
    Vaira, F
    Vigani, A
    Losardo, P
    Bertelli, G
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2679 - 2682
  • [9] 5-fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma - A randomized trial
    Tsavaris, NB
    Tentas, K
    Kosmidis, P
    Mylonakis, N
    Sakelaropoulos, N
    Kosmas, C
    Lisaios, B
    Soumilas, A
    Mandrekois, D
    Tsetis, A
    Klonaris, C
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (05): : 517 - 521
  • [10] CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL VERSUS 5-FLUOROURACIL FOR CARCINOMA OF LARGE-INTESTINE IN ADVANCED PHASE
    SCANNI, A
    TOMIROTTI, M
    BIRAGHI, M
    ANNIBALI, E
    DELBIANCO, S
    MINERVA MEDICA, 1980, 71 (10) : 799 - 801